Biological markers in heart rhythm patients getting ablation
Part of Heart & circulation clinical trials.
This study looks at unique biological markers in people who are getting a catheter ablation for certain types of fast or irregular heartbeats. It may help find patterns that improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are scheduled to have a catheter ablation for VT, PVCs, or AVNRT (a type of fast heartbeat).
- You do not have an active infection or inflammatory disease.
- You are not pregnant.
- You are able to follow study procedures and have a life expectancy longer than one year (unless the only reason for a shorter life expectancy is your arrhythmia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ECG to better tell apart different types of fast heart rhythms in people scheduled for a procedure called ablation. The goal is to improve diagnosis and treatment for conditions like atrial fibrillation and other supraventricular tachycardias.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
This study looks at a protein in your blood called BDNF and how it relates to heart muscle changes in people having their first ablation procedure for persistent atrial fibrillation (a common type of irregular heartbeat). Researchers want to understand if this protein might help predict who will benefit most from the procedure.
Hear when a new Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.